Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients

New Microbiologica

Volumn 20, Issue 2, 1997, Pages 105-114

  Cristallo, A ^a   Gambaro, F ^b   Biamonti, G ^c   Ferrante, P ^d   Battaglia, M ^c   Cereda, P M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Pharmacia Biotech   (Italy)

^c CNR   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CEREBROSPINAL FLUID; CORONAVIRUS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEIC ACID HYBRIDIZATION; OPEN READING FRAME; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS INFECTION;

CORONAVIRUS; CORONAVIRUS 229E, HUMAN; CORONAVIRUS INFECTIONS; CORONAVIRUS OC43, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; NUCLEIC ACID HYBRIDIZATION; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0031115531     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BARIC, R.S., STOHLMAN, S.A., and LAI, M.M.C. (1983). Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. Journal of Virology, 48, 633-640.
2. BARIC, R.S., STOHLMAN, S.A., RAZAVI, M.K., and LAI, M.M.C. (1985). Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Research, 3, 19-33.
3. BOURSNELL, M.E., BROWN, T.D., FOULDS, I.J., GREEN, P.F., TOMLEY, F.M., and BINNS, M.M. (1987). Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. Journal of General Virology, 68, 57-77.
4. BROWN, T.D., BOURSNELL, M.E., and BINNS, M.M. (1984). A leader sequence is present on mRNA A of avian infectious bronchitis virus. Journal of General Virology, 65, 1437-1442.
5. BURKS, J.S., DEVALD, B.L., JANKOVSKY, L.D., and GERDES, J.C. (1980). Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science, 209, 933-934.
6. CABIRAC, G.F., SOLKE, K.F., ZHANG, J.-Y., HOEL, K., BUTUNOI, C., CAI, G.-Y., JOHNSON, S., and MURRAY, R.S. (1994). Entry of coronavirus into primate CNS following peripheral infection. Microbial Pathogenesis, 16, 349-357.
7. COLE, G.A., NATHANSON, N., and PRENDERGAST, R.A. (1972). Requirement for thetabearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature, 238, 335-337.
8. DALGLEISH, A.G., BEVERLEY, P.R.C., CRAWFORD, D.H., GREAVES, M.F., and WEISS, R.A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, 312, 763-767.
9. DVEKSLEER, O.S., PENSIERO, M.N., CARDELLICHIO, C.B., WILLLGMS, R.K., JIANG, G.-S., HOLMES, K.V., and DIEFFENBACH, C.W. (1991). Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. Journal of Virology, 65, 6881 -6891.
10. GERNA, G., ACHILLI, G., CATTANEO, E., and CEREDA, P.M. (1978a). Determination of coronavirus 229E antibody by an immune-adherence hemagglutination method. Journal of Medical Virology, 2, 215-223.
11. GERNA, G., CATTANEO, E., CEREDA, P.M., and REVELLO, M.G. (1978b). Seroepidemiologic study of human coronavirus OC43 infections in Italy. Bollettino dell'Istituto Sieroterapico Milanese, 57, 535-542.
12. GERNA, G., CATTANEO, E., CEREDA, P.M., REVELLO, M.G., and ACHILLI, G. (1980). Corona-virus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay. Proceedings of the Society for Experimental Biology and Medicine, 163, 360-366.
13. GIULIAN, D., VACA, K., and NOONAN, C.A. (1990). Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science, 250, 1593-1596.
14. HEYES, M.P., BREW, B.J., MARTIN, A., and PRICE, R.W. (1991). Quinolinic acid and cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Annals of Neurology, 29, 202-209.
15. HULTMAN, T., BERGH, S., MOKS, T., and UHLEN, M. (1991). Bidirectional Solid-Phase Sequencing of in vitro-amplified plasmid DNA. BioTechniques, 10, 84-93.
16. KOOLEN, M.J.M., LOVE, S., WOUDA, W., CALAFAT, J., HORZINEK, M.C., and VAN DER ZEIJST, B.A.M. (1987). Induction of demyelination by a temperature-sensitive mutant of the coronavirus MHV-A59 is associated with restriction of viral replication in the brain. Journal of General Virology, 68, 703-714.
17. KRISTENSSON, K., and NORRBY, E. (1986). Persistence of RNA viruses in the central nervous system. Annual Review of Microbiology, 40, 159-184.
18. LAGERKVIST, A., STEWART, J., LAGERSTROM-FERMER, M., and LANDEGREN, U. (1994). Manifold sequencing: Efficient processing of large sets of sequencing reactions. Proceedings of the National Academy of Sciences, USA 91, 2245-2249.
19. LAI, M.M.C., PATTON, C.D., and STOHLMAN, S.A. (1982). Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. Journal of Virology, 44, 487-492.
20. LAI, M.M.C. (1986). Coronavirus leader-RNA-primed transcription: an alternative mechanism to RNA splicing. Bioessays, 5, 257-260.
21. LAI, M.M.C. (1990). Coronavirus: organization, replication and expression of genome. Annual Review of Microbiology, 44, 303-333.
22. LIEBERT, U.G., LININGTON, C., and TER MEULEN, V. (1988). Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats. Journal of Neuroimmunology, 17, 103-118.
23. LINK, H., and TIBBING, G. (1977). Principles of al-bumin and IgG analysis in neurological disorders. Evaluation of IgG synthesis within the Central Nervous System in multiple sclerosis. Scandinavian Journal of Clinical and Laboratory Investigation, 37, 397-401.
24. MURRAY, R.S., BROWN, B., BRIAN, D., and CABIRAC, G.F. (1992). Detection of coronavirus RNA and antigen in multiple sclerosis brain. Annals of Neurology, 31, 525-533.
25. NAGASHIMA, K., WEGE, H., MEYERMANN, R., and TER MEULEN, V. (1978). Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathologica, 44, 63-70.
26. PADGETT, B.L., WALTER, D.L., ZURHEIN, G.M., EDEROODE, R.J., and DESSEL, B.H. (1971). Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet, i, 1257-1260.
27. PEARSON, J., and MIMS, C.A. (1985). Differential susceptibility of cultured neural cells to the human coronavirus OC43. Journal of Virology, 53, 1016-1019.
28. POSER, C.M., PATY, D.W., SCHEINBERG, L., MCDONALD, W.I., DAVIS, F.A., EBERS, G.C., JOHNSON, K.P., SIBLEY, W.A., SILBERBERG, D.H., and TOURTELLOTTE, W.W. (1983). New diagnostic criteria for multiple sclerosis. An-nals of Neurology, 13, 227-231.
29. QUAGLIARELLO, V.J., WISPELWEY, B., LONG, W.J.JR., and SCHEID, W.M. (1991). Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Journal of Clinical Investigation, 87, 1360-1366.
30. STEWART, J.N., MOUNIR, S., and TALBOT, P.J. (1992). Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology, 191, 502-505.
31. STITZ, L., DIETZSCHOLD, B., and CARBONE, K.M. (1995). Immunopathogenesis of Borna disease. In: Koprowski, H., and Lipkin, W.I. Eds, Borna disease. Springer-Verlag KG, Heidelberg.
32. STONE, T.W., and CONNICK, J.H. (1985). Quinolinic acid and other kynurenines in the central nervous system. Neuroscience, 15, 597-617.
33. TALBOT, P.J., PAQUETTE, J.S., CIURLI, C., ANTEL, J.P., and QUELLET, F. (1996). Myelin basic pro-tein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Annals of Neurology. 39, 233-240.
34. TANAKA, R., IWASAKI, Y., and KOPROWSKI, H. (1976). Intracisternal virus-like particles in brain of a multiple sclerosis patient. Journal of the Neurological Sciences, 28, 121-126.
35. THOMPSON, J.A., PANDE, H., PAXTON, R.J., SHIVELY, L., PADMA, A., SIMMER, R.L., TOOD, C.W., RIGGS, A.D., and SHIVELY, J.E. (1987). Molecular cloning of a gene belonging to the carcinoembryonic antigen gene family and discussion of a domain model. Proceedings of the National Academy of Sciences, USA 84, 2965-2969.
36. WEIMER, L.P., HERDON, R.M., NARAYAN, O., and JOHNSON, R.T. (1972). Further studies of simian virus- 40-like virus isolated from human brain. Journal of Virology, 10, 147-152.
37. WIGDAHL, B., and KUNSCH, C. (1990). Human immunodeficiency virus infection and neurologic dysfunction. Progress in Medical Virology, 37, 1-46.
38. WILLIAMS, R.K, JIANG, G.-S., SNYDER, S.W., FRANA, M.F., and HOLMES, K.V. (1990). Purification of 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV resistant SJL/J mice. Journal of Virology, 64, 3817-3823.
39. WILLIAMS, R.K., JIANG, G.-S., and HOLMES, K.V. (1991). Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proceedings of the National Academy of Sciences, USA 88, 5533-5536.
40. YEAGER, C.L, ASHMUN, R.A., WILLIAMS, R.K., CARDELLICHIO, C.B., SHAPIRO, L.H., LOOK, T., and HOLMES, K.V. (1992). Human aminopeptidase N is a receptor for human coronavirus 229E. Nature, 357, 420-422.